Veradermics, Incorporated
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MANE | KRYS | VRCA | PVLA | TARS | PTGX | |
|---|---|---|---|---|---|---|
| Market cap | 5.11B | 9.83B | 68.89M | 1.94B | 3.48B | 9.37B |
| P/E (TTM) | — | 41.7 | — | — | — | 142.0 |
| Forward P/E | -45.6 | 35.8 | -2.7 | -17.9 | -206.7 | -727.5 |
| Price/book | 6.3 | 7.2 | 16.0 | 8.9 | 9.3 | 11.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +224.24% | +76.59% | −2.43% | +82.78% | +6.54% | +88.30% |
| Today | −6.49% | +0.14% | −2.43% | −3.16% | +1.69% | +0.80% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All MANE news ›Veradermics: The Momentum Is Building, But Know This Before H2 2026 Readouts
Veradermics (MANE) nears major Phase 3 VDPHL01 readouts in 2H26/1H27; review efficacy, cash runway to 2030, and valuation. See more here. - Veradermics Incorporated is positioned for major clinical catalysts, with key Phase 3 data for…
Veradermics (NYSE:MANE) Stock Falls 8.1% - Here's What Happened
Veradermics, Incorporated (NYSE:MANE - Get Free Report) fell 8.1% during mid-day trading on Tuesday. The stock traded as low as $110.13 and last traded at $109.2560. Approximately 523,982 shares changed hands during trading, a decline of…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketbeat.com1
-
seekingalpha.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.